Author(s):
Sivakumar Kannan, Anup Naha, Robindra Ramnarine Singh, Punit Bansal, Vinod C Nayak, Sandeep Goud
Email(s):
anupnaha.mahe@gmail.com
DOI:
10.5958/0974-360X.2020.00744.1 
Address:
Sivakumar Kannan1, Anup Naha1*, Robindra Ramnarine Singh2, Punit Bansal3, Vinod C Nayak4, Sandeep Goud5
1Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.
2Robin Singh Sports Academy, Dubai, UAE.
3Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.
4Department of Forensic Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.
5University of West Indies-Bahamas.
*Corresponding Author
Published In:
Volume - 13,
Issue - 9,
Year - 2020
ABSTRACT:
In Sports, the use of Prohibited substance or Prohibited methods or breaking Anti-Doping Rules Violations (ADRV) is termed as Doping. Anti-Doping Administrative Management System (ADAMS) has reported an average increase of 5.81% per year in the number of overall samples analysed (Olympic Sports and Non-Olympic Sports) for Anti-doping tests over the last 15 years (2003-2017). Since Mexico-1968 Olympic to Pyeongchang-2018 Olympic, 140 medals were stripped from sports persons due to Adverse Analytical Finding (AAF) at various sports. In sports, there are seven broad classes of substance that are categorized under doping. Several Anti-Doping organizations like National Anti-Doping Agency and World Anti-Doping Agency are working together to prevent doping from sports, providing equal chance to each sports person and to protect health of the athletes. Court of Arbitration for Sport (CAS) is the final court appeal for any National Anti-Doping Organization or whichever athlete or stakeholders who are breaking the ADRV. Pharmacists are playing an important role in sports by counseling athletes, advising physician and athletic personnel and enlightening the community about the ill effects of Anti-Doping. Sports Pharmacist with their knowledge and expertise can contribute immensely for spreading awareness about anti-doping practices among sports person and hence there is need to develop the concept of Sports Pharmacist in Indian Pharmaceutical Arena.
Cite this article:
Sivakumar Kannan, Anup Naha, Robindra Ramnarine Singh, Punit Bansal, Vinod C Nayak, Sandeep Goud. Sports Pharmacists: A Noble Evolving Professional in Indian Pharmaceutical Arena. Research J. Pharm. and Tech 2020; 13(9):4213-4218. doi: 10.5958/0974-360X.2020.00744.1
Cite(Electronic):
Sivakumar Kannan, Anup Naha, Robindra Ramnarine Singh, Punit Bansal, Vinod C Nayak, Sandeep Goud. Sports Pharmacists: A Noble Evolving Professional in Indian Pharmaceutical Arena. Research J. Pharm. and Tech 2020; 13(9):4213-4218. doi: 10.5958/0974-360X.2020.00744.1 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-9-32
REFERENCES:
1. World Anti-Doping [Internet]. [cited 2019 Jun 18]. Available from: www.wada-ama.org
2. WADA WAA. Prohibited List Wada 2019. World Anti-Doping Code. 2019;(January).
3. Currie A, Owen B. Oxford Medicine Online Sports Psychiatry ( Oxford Psychiatry Library ). 2016;1–24.
4. List of athletes stripped of their medals PyeongChang 2018 Rio 2016 Sochi 2014 London 2012. 2018;
5. Summary E, Report S, Report TA, Report ABP, Analysis B. 2017 Anti‐Doping Testing Figures. 2017;9.
6. World Anti Doping Agency. 2015 Anti-Doping Testing Figures. Lab Rep ABP Report-Blood Anal [Internet]. 2016;122:117–239. Available from: https://www.wada-ama.org/sites/default/ files/resources/files/2015_wada_anti-doping_testing_figures_ report_0.pdf
7. Findings AA, Findings A. 2008 Laboratory Statistics. 2008; Available from: https://www.wada-ama.org/sites/default/files/ resources/files/WADA_LaboStatistics_2008.pdf
8. Findings AA. Overview of Results Comparison of years 2003 to 2007. 2007;1–13.
9. Analytical A. 2004 Laboratory Statistics. 2004; Available from: https://www.wada-ama.org/sites/default/files/resources/files/ WADA_LaboStatistics_2004.pdf
10. World Anti-Doping Agency. Overview of results reported by the 31 IOC/WADA-accredited Laboratories. 2003. p. 1–11.
11. Analytical A. 2005 Adverse Analytical Findings Reported by Accredited Laboratories Differentiation between Olympic and Non-Olympic Sports A Samples Analyzed A Samples % Adverse Adverse Analytical Findings*. 2005; Available from: https://www.wada-ama.org/sites/default/files/resources/files/ WADA_LaboStatistics_2005.pdf
12. WADA. 2014 Anti-Doping Testing Figures Report. Lab Rep [Internet]. 2014;16:202. Available from: https://www.wada-ama.org/sites/default/files/wada_2014_anti-doping-testing-figures_full-report_en.pdf
13. WADA. Testing Figures Report. Montr Canada [Internet]. 2012; Available from: http://www.wada-ama.org/Documents/ Resources/Testing-Figures/WADA-2012-Anti-Doping-Testing-Figures-Report-EN.pdf
14. Findings AA, Findings A. Reported by Accredited Laboratories Overview of Results Reported by Accredited Laboratories Comparison of Years 2003 to 2010. 2010;
15. World Anti-Doping Agency. Testing Figures by Laboratory 2013. 2013;16:1–171.
16. World Anti-Doping Agency. 2011 Laboratoy Testing Figures. 2011;1–18. Available from: http://www.wada-ama.org/ Documents/Resources/Testing-Figures/WADA-2011-Laboratory-Testing-Figures.pdf
17. Findings AA, Findings A. 2009 Laboratory Statistics. 2009; Available from: https://www.wada-ama.org/sites/default/files /resources/files/WADA_2009_LaboratoryStatisticsReport_Final.pdf
18. World Anti Doping Agency. 2016 Anti-Doping Testing Figures - Executive Summary. Anti Doping Test Fig [Internet]. 2017;9:288–323. Available from: https://www.wada-ama.org/sites/default/files/resources/files/2016_anti-doping_ testing_figures.pdf
19. Adverse AA. 2006 Laboratory Statistics. 2006; Available from: https://www.wada-ama.org/sites/default/files/resources/files/ WADA_LaboStatistics_2006.pdf
20. Who We Are | World Anti-Doping Agency [Internet]. [cited 2019 Mar 13]. Available from: https://www.wada-ama.org/en/who-we-are
21. Anti-Doping | Commonwealth Games Federation [Internet]. [cited 2019 Apr 23]. Available from: https://thecgf.com/anti-doping
22. Olympic Drug Testing - WADA and the IOC Fight Against Doping [Internet]. [cited 2019 Apr 29]. Available from: https://www.olympic.org/fight-against-doping
23. International Paralympic Committee | IPC | International Paralympic Committee [Internet]. [cited 2019 Apr 29]. Available from: https://www.paralympic.org/
24. India - National Olympic Committee (NOC) [Internet]. [cited 2019 May 6]. Available from: https://www.olympic.org/india
25. National Anti Doping Agency - Anti Doping Awareness Programme [Internet]. [cited 2019 Jul 30]. Available from: https://www.nadaindia.org/en/anti-doping-awareness-programme
26. UNESCO and WADA | United Nations Educational, Scientific and Cultural Organization [Internet]. [cited 2019 Jul 12]. Available from: http://www.unesco.org/new/en/social-and-human-sciences/themes/anti-doping/unesco-and-wada/#topPage
27. WADA. World Anti-Doping Code International Standard: Testing and Investigations. 2019;(March):1–126. Available from: https://www.wada-ama.org/en/resources/world-anti-doping-program/international-standard-for-testing-and-investigations-isti
28. WADA. World Anti-Doping Code International Standard: Therapeutic Use Exemptions. 2019;(January):21. Available from: https://www.wada-ama.org/en/resources/therapeutic-use-exemption-tue/international-standard-for-therapeutic-use-exemptions-istue
29. Home - Tribunal Arbitral du Sport / Court of Arbitration for Sport [Internet]. [cited 2019 Aug 18]. Available from: https://www.tas-cas.org/en/index.html
30. Anti-Doping e-Learning (ADeL) | World Anti-Doping Agency [Internet]. [cited 2019 Jul 30]. Available from: https://www.wada-ama.org/en/what-we-do/education-prevention/ anti- doping-e-learning-adel
31. Research | World Anti-Doping Agency [Internet]. [cited 2019 Jul 30]. Available from: https://www.wada-ama.org/en/what-we-do/science-medical/research
32. Murofushi Y, Kawata Y, Kamimura A, Hirosawa M, Shibata N. Impact of anti-doping education and doping control experience on anti-doping knowledge in Japanese university athletes: A cross-sectional study. Subst Abus Treat Prev Policy. 2018;13(1):1–15.
33. Shibata K, Ichikawa K, Kurata N. Knowledge of pharmacy students about doping and the need for doping education: a questionnaire survey. BMC Res Notes. 2017;10(1):396.
34. Ambrose PJ. Educational opportunities and anti-doping roles and responsibilities for pharmacists. Yakugaku Zasshi. 2011;131(12):1761–4.
35. Vankhadlo A, Planida E. Knowledge, attitudes and practice of coaches belonging to different generations in relation to doping behaviour or athletes. 2013 [cited 2019 Jun 17]; Available from: https://scholar.google.co.in/scholar?hl=en&as_sdt=0%2C5&q=Vankhadlo+A%2C+Planida+E.+Knowledge %2C+attitudes+and+practice+of+coaches+belonging+to+different+generations+in+relation+to+doping+behaviour+or+athletes.&btnG=
36. Wada WA-DA. Anti-Doping: important facts and highlights from Wada’s Athlete Guide. 2015;
37. International Pharmaceutical Federation. FIP Guidelines The role of the pharmacist in the fight against doping in sport. 2014;1–4. Available from: https://www.fip.org/www/uploads/ database_file.php?id=369&table_id=